Stevanato Group S.p.A (STVN) Non-Current Assets (2020 - 2025)
Stevanato Group S.p.A (STVN) posted quarterly Non-Current Assets of $1.9 billion for Q4 2025, up 20.34% year-over-year from $1.5 billion in Q4 2024, and up 20.34% quarter-over-quarter from $1.5 billion in Q4 2024.
Stevanato Group S.p.A (STVN) Non-Current Assets (2020 - 2025) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Non-Current Assets for 6 consecutive years, with $1.9 billion the latest figure, recorded in Q4 2025.
- In Q4 2025, Non-Current Assets rose 20.34% year-over-year to $1.9 billion; the TTM figure through Dec 2025 stood at $5.5 billion (up 28.54% YoY), while the FY2025 annual figure was $1.9 billion, up 20.34% from the prior year.
- Non-Current Assets improved to $1.9 billion in Q4 2025 per STVN's latest filing, from $1.5 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $1.9 billion in Q4 2025 and bottomed at $597.9 million in Q2 2021.
- Historically, Non-Current Assets has averaged $1.1 billion across 5 years, with a median of $830.4 million in 2022.
- Annual changes were most pronounced in 2021 — Non-Current Assets advanced 11.63% — and 2023, when it soared 56.74%.
- Stevanato Group S.p.A's Non-Current Assets stood at $632.5 million in 2021, then jumped by 31.3% to $830.4 million in 2022, then jumped by 56.74% to $1.3 billion in 2023, then grew by 18.96% to $1.5 billion in 2024, then rose by 20.34% to $1.9 billion in 2025.
- Business Quant data shows STVN's Non-Current Assets at $1.9 billion in Q4 2025, $1.5 billion in Q4 2024, and $1.3 billion in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.80 Bn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.86 Bn |
| Dec 31, 2024 | 1.55 Bn |
| Dec 31, 2023 | 1.30 Bn |
| Dec 31, 2022 | 830.40 Mn |
| Dec 31, 2021 | 632.47 Mn |
| Sep 30, 2021 | 606.83 Mn |
| Jun 30, 2021 | 597.92 Mn |
| Dec 31, 2020 | 566.58 Mn |